Covid-19 induced superimposed bacterial infection

References

• Akira, S., Uematsu, S., & Takeuchi, O. (2006). Pathogen recognition and innate immunity. Cell, 124(4), 783–801. https://doi.org/10.1016/j.cell.2006.02.015
   PubMed Web of Science ®Google Scholar
• Avadhanula, V., Rodriguez, C. A., Devincenzo, J. P., Wang, Y., Webby, R. J., Ulett, G. C., & Adderson, E. E. (2006). Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner. Journal of Virology, 80(4), 1629–1636. https://doi.org/10.1128/JVI.80.4.1629-1636.2006
   PubMed Web of Science ®Google Scholar
• Basler, C. F., & García-Sastre, A. (2002). Viruses and the type I interferon antiviral system: Induction and evasion. International Reviews of Immunology, 21(4–5), 305–337. https://doi.org/10.1080/08830180213277
   PubMedGoogle Scholar
• Beadling, C., & Slifka, M. K. (2004). How do viral infections predispose patients to bacterial infections? Current Opinion in Infectious Diseases, 17(3), 185–191. https://doi.org/10.1097/00001432-200406000-00003
   PubMed Web of Science ®Google Scholar
• Bragonzi, A., Copreni, E., de Bentzmann, S., Ulrich, M., & Conese, M. (2004). Airway epithelial cell-pathogen interactions. Journal of Cystic Fibrosis, 3(suppl 2), 197–201. https://doi.org/10.1016/j.jcf.2004.05.041
   PubMedGoogle Scholar
• Bulut, Y., Güven, M., Otlu, B., Yenişehirli, G., Aladağ, I., Eyibilen, A., & Doğru, S. (2007). Acute otitis media and respiratory viruses. European Journal of Pediatrics, 166(3), 223–228. https://doi.org/10.1007/s00431-006-0233-x
   PubMed Web of Science ®Google Scholar
• Chamaillard, M., Hashimoto, M., Horie, Y., Masumoto, J., Qiu, S., Saab, L., Ogura, Y., Kawasaki, A., Fukase, K., Kusumoto, S., Valvano, M. A., Foster, S. J., Mak, T. W., Nuñez, G., & Inohara, N. (2003). An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nature Immunology, 4(7), 702–707. https://doi.org/10.1038/ni945
   PubMed Web of Science ®Google Scholar
• Chavez, S., Long, B., Koyfman, A., & Liang, S. Y. (2020). Coronavirus Disease (COVID-19): A primer for emergency physicians. The American Journal of Emergency Medicine. https://doi.org/10.1016/j.ajem.2020.03.036
   Google Scholar
• Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ma, K., Xu, D., Yu, H., Wang, H., Wang, T., Guo, W., Chen, J., Ding, C., Zhang, X., Huang, J., Han, M., Li, S., Luo, X., Zhao, J., & Ning, Q. (2020). Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study [published correction appears in BMJ. 2020 Mar 31;368: M 1295]. BMJ (Clinical Research ed.).), 368, m1091. Published 2020 Mar 26. https://doi.org/10.1136/bmj.m1091
   PubMed Web of Science ®Google Scholar
• Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., Xia, J., Yu, T., Zhang, X., & Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet (London, England), 395(10223), 507–513. https://doi.org/10.1016/S0140-6736(20)30211-7
   PubMed Web of Science ®Google Scholar
• Cook, D. N., Pisetsky, D. S., & Schwartz, D. A. (2004). Toll-like receptors in the pathogenesis of human disease. Nature Immunology, 5(10), 975–979. https://doi.org/10.1038/ni1116
   PubMed Web of Science ®Google Scholar
• de Jong, E., van Oers, J. A., Beishuizen, A., Vos, P., Vermeijden, W. J., Haas, L. E., Loef, B. G., Dormans, T., van Melsen, G. C., Kluiters, Y. C., Kemperman, H., van den Elsen, M. J., Schouten, J. A., Streefkerk, J. O., Krabbe, H. G., Kieft, H., Kluge, G. H., van Dam, V. C., van Pelt, J., … de Lange, D. W. (2016). Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: A randomised, controlled, open-label trial. Lancet Infectious Diseases, 16(7), 819–827. https://doi.org/10.1016/S1473-3099(16)00053-0
   PubMed Web of Science ®Google Scholar
• Didierlaurent, A., Goulding, J., Patel, S., Snelgrove, R., Low, L., Bebien, M., Lawrence, T., van Rijt, L. S., Lambrecht, B. N., Sirard, J. C., & Hussell, T. (2008). Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. The Journal of Experimental Medicine, 205(2), 323–329. https://doi.org/10.1084/jem.20070891
   PubMed Web of Science ®Google Scholar
• Doughty, L., Nguyen, K., Durbin, J., & Biron, C. (2001). A role for IFN-alpha beta in virus infection-induced sensitization to endotoxin. Journal of Immunology (Baltimore, MD: 1950)), 166(4), 2658–2664. https://doi.org/10.4049/jimmunol.166.4.2658
   PubMed Web of Science ®Google Scholar
• Elfiky, A. A. (2020). Natural products may interfere with SARS-CoV-2 attachment to the host cell. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/10.1080/07391102.2020.1761881
   Web of Science ®Google Scholar
• Elmezayen, A. D., Al-Obaidi, A., Şahin, A. T., & Yelekçi, K. (2020). Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/10.1080/07391102.2020.1758791
   Web of Science ®Google Scholar
• Gautret, P., Lagier, J. C., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V. E., Dupont, H. T., Honoré, S., Colson, P., Chabrière, E., La Scola, B., Rolain, J. M., Brouqui, P., & Raoult, D. (2020). Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial. International Journal of Antimicrobial Agents, 105949. https://doi.org/10.1016/j.ijantimicag.2020.105949
   PubMed Web of Science ®Google Scholar
• Girardin, S. E., Boneca, I. G., Carneiro, L. A. M., Antignac, A., Jéhanno, M., Viala, J., Tedin, K., Taha, M.-K., Labigne, A., Zähringer, U., Coyle, A. J., DiStefano, P. S., Bertin, J., Sansonetti, P. J., & Philpott, D. J. (2003). Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science (New York, N.Y.).), 300(5625), 1584–1587. https://doi.org/10.1126/science.1084677
   PubMed Web of Science ®Google Scholar
• Goyal, P., Choi, J. J., Pinheiro, L. C., Schenck, E. J., Chen, R., Jabri, A., Satlin, M. J., Campion, T. R., Jr, Nahid, M., Ringel, J. B., Hoffman, K. L., Alshak, M. N., Li, H. A., Wehmeyer, G. T., Rajan, M., Reshetnyak, E., Hupert, N., Horn, E. M., Martinez, F. J., Gulick, R. M., … Safford, M. M. (2020). Clinical Characteristics of Covid-19 in New York City. The New England Journal of Medicine. https://doi.org/10.1056/NEJMc2010419
   Google Scholar
• Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J., Liu, L., Shan, H., Lei, C.-L., & Hui, D. S. (2020). Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv. doi: https://doi.org/ https://doi.org/10.1101/2020.02.06.20020974
   Google Scholar
• He, Y., Li, W., Wang, Z., Chen, H., Tian, L., & Liu, D. (2020). Nosocomial infection among patients with COVID-19: A retrospective data analysis of 918 cases from a single center in Wuhan, China. Infection Control and Hospital Epidemiology, 1–2. https://doi.org/10.1017/ice.2020.126
   Google Scholar
• Hendaus, M. A. (2019). Why are children with bronchiolitis at risk of urinary tract infections? Risk Management and Healthcare Policy, 12, 251–254. https://doi.org/10.2147/RMHP.S222470
   PubMed Web of Science ®Google Scholar
• Hendaus, M. A. (2020, May 12). Remdesivir in the treatment of Coronavirus Disease 2019 (COVID-19): A simplified summary. Journal of Biomolecular Structure and Dynamics, 2020, 1–10. https://doi.org/10.1080/07391102.2020.1767691
   Web of Science ®Google Scholar
• Hendaus, M. A., Jomha, F. A., & Alhammadi, A. H. (2015). Virus-induced secondary bacterial infection: A concise review. Therapeutics and Clinical Risk Management, 11, 1265–1271. https://doi.org/10.2147/TCRM.S87789
   PubMed Web of Science ®Google Scholar
• Holmes, A. H., Moore, L. S., Sundsfjord, A., Steinbakk, M., Regmi, S., Karkey, A., Guerin, P. J., & Piddock, L. J. (2016). Understanding the mechanisms and drivers of antimicrobial resistance. Lancet (London, England), 387(10014), 176–187. https://doi.org/10.1016/S0140-6736(15)00473-0
   PubMed Web of Science ®Google Scholar
• Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., … Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020 Jan 30]. The Lancet, 395(10223), 497–‐506. https://doi.org/10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Inohara, N., Ogura, Y., Fontalba, A., Gutierrez, O., Pons, F., Crespo, J., Fukase, K., Inamura, S., Kusumoto, S., Hashimoto, M., Foster, S. J., Moran, A. P., Fernandez-Luna, J. L., & Nuñez, G. (2003). Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. The Journal of Biological Chemistry, 278(8), 5509–5512. https://doi.org/10.1074/jbc.C200673200
   PubMed Web of Science ®Google Scholar
• Joshi, S. (2010). Hospital antibiogram: A necessity. Indian Journal of Medical Microbiology, 28(4), 277–280. https://doi.org/10.4103/0255-0857.71802
   PubMed Web of Science ®Google Scholar
• Joshi, R. S., Jagdale, S. S., Bansode, S. B., Shankar, S. S., Tellis, M. B., Pandya, V. K., Chugh, A., Giri, A. P., & Kulkarni, M. J. (2020). Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease$. Journal of Biomolecular Structure and Dynamics, 1–16. https://doi.org/10.1080/07391102.2020.1760137
   Google Scholar
• Kanneganti, T. D., Lamkanfi, M., & Nunez, G. (2007). Intracellular NOD-like receptors in host defense and disease. Immunity, 27(4), 549–559. https://doi.org/10.1016/j.immuni.2007.10.002
   PubMed Web of Science ®Google Scholar
• Katze, M. G., He, Y., & Gale, M. Jr. (2002). Viruses and interferon: A fight for supremacy. Nature Reviews Immunology, 2(9), 675–687. https://doi.org/10.1038/nri888
   PubMed Web of Science ®Google Scholar
• Khan, R. J., Jha, R. K., Amera, G. M., Jain, M., Singh, E., Pathak, A., Singh, R. P., Muthukumaran, J., & Singh, A. K. (2020). Targeting SARS-CoV-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2’-O-ribose methyltransferase. Journal of Biomolecular Structure and Dynamics, 1–14. https://doi.org/10.1080/07391102.2020.1753577
   Google Scholar
• Kim, Y. G., Park, J. H., Reimer, T., Baker, D. P., Kawai, T., Kumar, H., Akira, S., Wobus, C., & Núñez, G. (2011). Viral infection augments Nod1/2 signaling to potentiate lethality associated with secondary bacterial infections. Cell Host & Microbe, 9(6), 496–507. https://doi.org/10.1016/j.chom.2011.05.006
   PubMed Web of Science ®Google Scholar
• Kim, D., Quinn, J., Pinsky, B., Shah, N. H., & Brown, I. (2020). Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens. JAMA, 323(20), 2085–2086. https://doi.org/10.1001/jama.2020.6266
   Google Scholar
• Lehtinen, P., Jartti, T., Virkki, R., Vuorinen, T., Leinonen, M., Peltola, V., Ruohola, A., & Ruuskanen, O. (2006). Bacterial coinfections in children with viral wheezing. European Journal of Clinical Microbiology & Infectious Diseases : official Publication of the European Society of Clinical Microbiology, 25(7), 463–469. https://doi.org/10.1007/s10096-006-0166-3
   PubMed Web of Science ®Google Scholar
• Mallia, P., & Johnston, S. L. (2007). Influenza infection and COPD. International Journal of Chronic Obstructive Pulmonary Disease, 2(1), 55–64. https://doi.org/10.2147/copd.2007.2.1.55
   PubMedGoogle Scholar
• McCullers, J. A., & Rehg, J. E. (2002). Lethal synergism between influenza virus and Streptococcus pneumoniae: Characterization of a mouse model and the role of platelet-activating factor receptor. The Journal of Infectious Diseases, 186(3), 341–350. https://doi.org/10.1086/341462
   PubMed Web of Science ®Google Scholar
• Meier, M. A., Branche, A., Neeser, O. L., Wirz, Y., Haubitz, S., Bouadma, L., Wolff, M., Luyt, C. E., Chastre, J., Tubach, F., Christ-Crain, M., Corti, C., Jensen, J.-U S., Deliberato, R. O., Kristoffersen, K. B., Damas, P., Nobre, V., Oliveira, C. F., Shehabi, Y., … Schuetz, P. (2019). Procalcitonin-guided antibiotic treatment in patients with positive blood cultures: A patient-level meta-analysis of randomized trials. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 69(3), 388–396. https://doi.org/10.1093/cid/ciy917
   PubMed Web of Science ®Google Scholar
• Message, S. D., & Johnston, S. L. (2004). Host defense function of the airway epithelium in health and disease: Clinical background. Journal of Leukocyte Biology, 75(1), 5–17. https://doi.org/10.1189/jlb.0703315
   PubMed Web of Science ®Google Scholar
• Morris, D. P. (2007). Bacterial biofilm in upper respiratory tract infections. Current Infectious Disease Reports, 9(3), 186–192. https://doi.org/10.1007/s11908-007-0030-3
   PubMedGoogle Scholar
• Nansen, A., & Randrup Thomsen, A. (2001). Viral infection causes rapid sensitization to lipopolysaccharide: Central role of IFN-alpha beta. Journal of Immunology (Baltimore, MD: 1950)), 166(2), 982–988. https://doi.org/10.4049/jimmunol.166.2.982
   PubMed Web of Science ®Google Scholar
• Passariello, C., Schippa, S., Conti, C., Russo, P., Poggiali, F., Garaci, E., & Palamara, A. T. (2006). Rhinoviruses promote internalisation of Staphylococcus aureus into non-fully permissive cultured pneumocytes. Microbes and Infection, 8(3), 758–766. https://doi.org/10.1016/j.micinf.2005.09.013
   PubMed Web of Science ®Google Scholar
• Rawlinson, W. D., Waliuzzaman, Z., Carter, I. W., Belessis, Y. C., Gilbert, K. M., & Morton, J. R. (2003). Asthma exacerbations in children associated with rhinovirus but not human metapneumovirus infection. The Journal of Infectious Diseases, 187(8), 1314–1318. https://doi.org/10.1086/368411
   PubMed Web of Science ®Google Scholar
• Rice, T. W., Rubinson, L., Uyeki, T. M., Vaughn, F. L., John, B. B., Miller, R. R., 3rd, Higgs, E., Randolph, A. G., Smoot, B. E., & Thompson, B. T. (2012). Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Critical Care Medicine, 40(5), 1487–1498. https://doi.org/10.1097/CCM.0b013e3182416f23
   PubMed Web of Science ®Google Scholar
• Rose, M. C., & Voynow, J. A. (2006). Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiological Reviews, 86(1), 245–278. https://doi.org/10.1152/physrev.00010.2005
   PubMed Web of Science ®Google Scholar
• Sahu, K. K., Mishra, A. K., & Lal, A. (2020). COVID-2019: Update on epidemiology, disease spread and management. Monaldi Archives for Chest Disease, 90(1). https://doi.org/10.4081/monaldi.2020.1292
   Google Scholar
• Sarma, P., Sekhar, N., Prajapat, M., Avti, P., Kaur, H., Kumar, S., Singh, S., Kumar, H., Prakash, A., Dhibar, D. P., & Medhi, B. (2020). In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). Journal of Biomolecular Structure and Dynamics, 1–11. https://doi.org/10.1080/07391102.2020.1753580
   Google Scholar
• Sinha, S. K., Shakya, A., Prasad, S. K., Singh, S., Gurav, N. S., Prasad, R. S., & Gurav, S. S. (2020), An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets. Journal of Biomolecular Structure and Dynamics [Epub ahead of print]. doi: 10.1080/07391102.2020.1762741
   Web of Science ®Google Scholar
• Tyrrell, D. A., & Bynoe, M. L. (1966). Cultivation of viruses from a high proportion of patients with colds. The Lancet, 287(7428), 76–77. https://doi.org/10.1016/S0140-6736(66)92364-6
   Google Scholar
• Umesh, K. D., Selvaraj, C., Singh, S. K., & Dubey, V. K. (2020). Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2020.1763202
   Google Scholar
• Vareille, M., Kieninger, E., Edwards, M. R., & Regamey, N. (2011). The airway epithelium: Soldier in the fight against respiratory viruses. Clinical Microbiology Reviews, 24(1), 210–229. https://doi.org/10.1128/CMR.00014-10
   PubMed Web of Science ®Google Scholar
• Velavan, T. P., & Meyer, C. G. (2020). The COVID-19 epidemic. Tropical Medicine & International Health: TM & IH, 25(3), 278–280. https://doi.org/10.1111/tmi.13383
   PubMed Web of Science ®Google Scholar
• Vesa, S., Kleemola, M., Blomqvist, S., Takala, A., Kilpi, T., & Hovi, T. (2001). Epidemiology of documented viral respiratory infections and acute otitis media in a cohort of children followed from two to twenty-four months of age. The Pediatric Infectious Disease Journal, 20(6), 574–581.
   PubMed Web of Science ®Google Scholar
• Voynow, J. A., Gendler, S. J., & Rose, M. C. (2006). Regulation of mucin genes in chronic inflammatory airway diseases. American Journal of Respiratory Cell and Molecular Biology, 34(6), 661–665. https://doi.org/10.1165/rcmb.2006-0035SF
   PubMed Web of Science ®Google Scholar
• Wang, L., He, W., Yu, X., Hu, D., Bao, M., Liu, H., Zhou, J., & Jiang, H. (2020). Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up. Journal of Infection, pii: S0163-4453(20)30146-8. https://doi.org/10.1016/j.jinf.2020.03.019
   Google Scholar
• Wilson, R., Dowling, R. B., & Jackson, A. D. (1996). The biology of bacterial colonization and invasion of the respiratory mucosa . The European Respiratory Journal, 9(7), 1523–1530. https://doi.org/10.1183/09031936.96.09071523
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2020a). Coronavirus disease 2019 (COVID-19) Situation Report – 110. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200509covid-19-sitrep-110.pdf?sfvrsn=3b92992c_4
   Google Scholar
• World Health Organization. (2020b). Novel coronavirus (2019-nCoV) advice for the public. Geneva, Switzerland: World Health Organization. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public
   Google Scholar
• Xing, Q., Li, G., & Xing, Y. (2020). Precautions are needed for COVID-19 patients with coinfection of common respiratory pathogens. Preprint from medRxiv, 03 Mar 2020. https://doi.org/ https://doi.org/10.1101/2020.02.29.20027698PPR: PPR115450
   Google Scholar
• Yano, H., Okitsu, N., Hori, T., Watanabe, O., Kisu, T., Hatagishi, E., Suzuki, A., Okamoto, M., Ohmi, A., Suetake, M., Sagai, S., Kobayashi, T., & Nishimura, H. (2009). Detection of respiratory viruses in nasopharyngeal secretions and middle ear fluid from children with acute otitis media. Acta Oto-Laryngologica, 129(1), 19–24. https://doi.org/10.1080/00016480802032777
   PubMed Web of Science ®Google Scholar
• Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., Guan, L., Wei, Y., Li, H., Wu, X., Xu, J., Tu, S., Zhang, Y., Chen, H., & Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study [published correction appears in Lancet. 2020 Mar 28;395(10229):1038] [published correction appears in Lancet. 2020 Mar 28;395(10229):1038]. The Lancet, 395(10229), 1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar
• Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., & Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine, 382(8), 727–733. https://doi.org/10.1056/NEJMoa2001017
   PubMed Web of Science ®Google Scholar